ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,693Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 780

$1.34M Total Retail Price of All Prescriptions

Rank: 21 out of 780

708 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 708 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 708 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 21,283 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 1,356 940 1 2
HYDROCODONE-ACETAMINOPHEN 996 597 S3 2 1
LEVOTHYROXINE SODIUM 991 909 3 5
OMEPRAZOLE 870 651 4 3
LISINOPRIL 840 638 5 6
AMLODIPINE BESYLATE 765 651 6 4
FUROSEMIDE 739 616 7 7
TRAMADOL HCL 635 506 8 15
RANITIDINE HCL 568 445 9 39
POTASSIUM CHLORIDE 524 436 10 11
METFORMIN HCL 482 268 11 8
GABAPENTIN 447 321 12 13
MIRTAZAPINE 423 397 13 58
CARVEDILOL 423 367 13 14
GLIMEPIRIDE 413 307 15 30
BUSPIRONE HCL 412 357 16 125
HYDROCHLOROTHIAZIDE 408 291 17 10
CITALOPRAM HBR 369 306 18 23
NAMENDA 363 363 19 46
METOPROLOL TARTRATE 343 319 20 19
ZOLPIDEM TARTRATE 302 167 21 17
CLONIDINE HCL 300 231 22 28
DONEPEZIL HCL 296 276 23 31
LANTUS 233 163 24 71
SULFAMETHOXAZOLE-TRIMETHOPRIM 223 189 25 88
CLOPIDOGREL 207 166 26 34
AZITHROMYCIN 198 151 27 38
EXELON 187 187 28 132
LISINOPRIL-HYDROCHLOROTHIAZIDE 186 122 29 26
FAMOTIDINE 182 160 30 86
PENICILLIN V POTASSIUM 176 94 31 336
ATENOLOL 175 120 32 21
ENALAPRIL MALEATE 172 132 33 64
FENOFIBRATE 171 120 34 63
WARFARIN SODIUM 167 167 35 24
LOSARTAN POTASSIUM 166 116 36 18
AGGRENOX 161 153 37 233
KLOR-CON M20 150 111 38 57
METOPROLOL SUCCINATE 147 127 39 20
HALOPERIDOL 141 113 40 251
TAMSULOSIN HCL 140 116 41 36
SERTRALINE HCL 136 131 42 27
ESCITALOPRAM OXALATE 135 80 43 61
INSULIN SYRINGE 133 92 44 80
COLCRYS 131 118 45 131
VENTOLIN HFA 126 69 46 91
PHENYTOIN SODIUM EXTENDED 124 90 47 128
FLUOXETINE HCL 123 53 48 65
NOVOLIN 70-30 119 92 49 164
SPIRIVA 118 95 50 72
PLAVIX 114 102 51 45
ADVAIR DISKUS 113 61 52 68
DIOVAN 113 83 52 55
PREDNISONE 111 81 54 40
DIVALPROEX SODIUM 111 100 54 119
DIOVAN HCT 111 83 54 75
LOSARTAN-HYDROCHLOROTHIAZIDE 110 82 57 33
NOVOLIN R 110 89 57 212
CLOTRIMAZOLE-BETAMETHASONE 108 103 59 166
AMIODARONE HCL 101 86 60 139
PANTOPRAZOLE SODIUM 99 60 61 25
NEXIUM 99 44 61 22
VERAPAMIL ER 99 88 61 78
BUTRANS 97 80 S3 10 64 384
ATORVASTATIN CALCIUM 96 81 65 12
RISPERIDONE 95 95 66 98
CELEBREX 92 47 67 89
FLUTICASONE PROPIONATE 92 79 67 41
SPIRONOLACTONE 88 60 69 53
PAROXETINE HCL 88 44 69 69
LEVEMIR 86 63 71 198
HUMULIN R 86 73 71 228
SINGULAIR 85 53 73 73
CIPROFLOXACIN HCL 84 76 74 49
HYDRALAZINE HCL 83 46 75 54
BENAZEPRIL HCL 83 83 75 59
LOVAZA 83 52 75 183
PRAVASTATIN SODIUM 82 75 78 9
SYNTHROID 82 59 78 77
BUPROPION HCL SR 81 53 80 193
PROAIR HFA 81 35 80 62
GEMFIBROZIL 80 68 82 104
CYMBALTA 79 70 83 51
DIGOXIN 78 73 84 56
NATEGLINIDE 75 74 85 283
HUMULIN 70-30 74 49 86 106
METHOCARBAMOL 73 31 R 87 84
AMITRIPTYLINE HCL 73 31 R 87 48
SANTYL 73 73 87 311
ISOSORBIDE MONONITRATE ER 71 62 90 60
PRAMIPEXOLE DIHYDROCHLORIDE 71 36 90 156
POLYETHYLENE GLYCOL 3350 71 67 90 79
SUCRALFATE 70 52 93 149
TRAZODONE HCL 68 57 94 35
LYRICA 68 42 94 52
QUETIAPINE FUMARATE 67 50 96 81
SPIRONOLACTONE-HCTZ 67 50 96 204
TORSEMIDE 67 67 96 114
PROMETHAZINE HCL 66 54 R 99 66
MONTELUKAST SODIUM 66 36 99 120
CRESTOR 65 26 101 32
ATENOLOL-CHLORTHALIDONE 64 53 102 182
ZETIA 64 50 102 94
LATANOPROST 64 59 102 287
ALLOPURINOL 63 59 105 29
CARBIDOPA-LEVODOPA 63 63 105 124
BENZTROPINE MESYLATE 63 47 R 105 223
NITROSTAT 61 40 108 244
TOPIRAMATE 61 11 108 145
JANUVIA 58 47 110 85
LIDODERM 57 57 111 224
LOVASTATIN 57 49 111 47
LEVETIRACETAM 54 0 113 130
LEVOFLOXACIN 54 41 113 76
TRIAMTERENE-HCTZ 54 31 113 37
CARAFATE 54 44 113 269
DIVALPROEX SODIUM ER 53 48 117 216
ROPINIROLE HCL 52 28 118 87
LABETALOL HCL 52 22 118 159
SYMBICORT 50 31 120 181
AMITIZA 50 38 120 288
AMLODIPINE BESYLATE-BENAZEPRIL 50 43 120 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.